Form 8-K - Current report:
SEC Accession No. 0001193125-25-181736
Filing Date
2025-08-15
Accepted
2025-08-15 15:18:06
Documents
14
Period of Report
2025-08-14
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d858618d8k.htm   iXBRL 8-K 27916
2 EX-99.1 d858618dex991.htm EX-99.1 7685
6 GRAPHIC g858618g0815214053793.jpg GRAPHIC 2780
  Complete submission text file 0001193125-25-181736.txt   158080

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhc-20250814.xsd EX-101.SCH 2511
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20250814_lab.xml EX-101.LAB 18439
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20250814_pre.xml EX-101.PRE 11224
16 EXTRACTED XBRL INSTANCE DOCUMENT d858618d8k_htm.xml XML 3709
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)